Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2005 4
2006 3
2007 1
2008 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione Investigators. Levantesi G, et al. Among authors: valagussa f. J Am Coll Cardiol. 2005 Jul 19;46(2):277-83. doi: 10.1016/j.jacc.2005.03.062. J Am Coll Cardiol. 2005. PMID: 16022955 Free article. Clinical Trial.
Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, Ceci V, Chieffo C, Gattone M, Griffo R, Schweiger C, Tavazzi L, Urbinati S, Valagussa F, Vanuzzo D; GOSPEL Investigators. Giannuzzi P, et al. Among authors: valagussa f. Arch Intern Med. 2008 Nov 10;168(20):2194-204. doi: 10.1001/archinte.168.20.2194. Arch Intern Med. 2008. PMID: 19001195 Clinical Trial.
Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade.
Giannattasio C, Achilli F, Failla M, Capra A, Vincenzi A, Valagussa F, Mancia G. Giannattasio C, et al. Among authors: valagussa f. J Am Coll Cardiol. 2002 Apr 17;39(8):1275-82. doi: 10.1016/s0735-1097(02)01755-2. J Am Coll Cardiol. 2002. PMID: 11955844 Free article. Clinical Trial.
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F; GISSI-Prevenzione Investigators. Marchioli R, et al. Among authors: valagussa f. Circulation. 2002 Apr 23;105(16):1897-903. doi: 10.1161/01.cir.0000014682.14181.f2. Circulation. 2002. PMID: 11997274 Clinical Trial.
High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarction.
Avanzini F, Alli C, Boccanelli A, Chieffo C, Franzosi MG, Geraci E, Maggioni AP, Marfisi RM, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione investigators. Avanzini F, et al. Among authors: valagussa f. J Hypertens. 2006 Dec;24(12):2377-85. doi: 10.1097/01.hjh.0000251897.40002.bf. J Hypertens. 2006. PMID: 17082719
[Determinants of late-onset heart failure in myocardial infarction survivors: GISSI Prevenzione trial results].
Macchia A, Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; Investigadores del estudio Grupo Italiano para el Estudio de la Supervivencia en el Infarto de Miocardio Prevenzione. Macchia A, et al. Among authors: valagussa f. Rev Esp Cardiol. 2005 Nov;58(11):1266-72. Rev Esp Cardiol. 2005. PMID: 16324579 Free article. Spanish.
GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction: the GOSPEL study. A trial from the Italian Cardiac Rehabilitation Network: rationale and design.
Giannuzzi P, Temporelli PL, Maggioni AP, Ceci V, Chieffo C, Gattone M, Griffo R, Marchioli R, Schweiger C, Tavazzi L, Urbinati S, Valagussa F; GOSPEL. Giannuzzi P, et al. Among authors: valagussa f. Eur J Cardiovasc Prev Rehabil. 2005 Dec;12(6):555-61. doi: 10.1097/01.hjr.0000186623.60486.26. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 16319545 Clinical Trial.
Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
Macchia A, Levantesi G, Franzosi MG, Geraci E, Maggioni AP, Marfisi R, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione Investigators. Macchia A, et al. Among authors: valagussa f. Eur J Heart Fail. 2005 Aug;7(5):904-9. doi: 10.1016/j.ejheart.2005.04.008. Eur J Heart Fail. 2005. PMID: 16087142 Free article.
13 results